CNS Pharmaceuticals, Inc. (CNSP) vs Imunon, Inc. (IMNN)
CNS Pharmaceuticals, Inc. and Imunon, Inc. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Imunon, Inc. are of similar size ($7.5M and $7.3M). Across the 10 metrics below, CNS Pharmaceuticals, Inc. leads on 9 and Imunon, Inc. on 1.
Valuation
Profitability
| Metric | CNSP | IMNN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (106.62%) | (641.02%) | (57.72%) |
| Return on assets | (91.64%) | (123.93%) | (49.22%) |
| Return on invested capital | 0.00% | (324.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack